81 related articles for article (PubMed ID: 21775155)
1. Labeling and enrichment of Arabidopsis thaliana matrix metalloproteases using an active-site directed, marimastat-based photoreactive probe.
Lenger J; Kaschani F; Lenz T; Dalhoff C; Villamor JG; Köster H; Sewald N; van der Hoorn RA
Bioorg Med Chem; 2012 Jan; 20(2):592-6. PubMed ID: 21775155
[TBL] [Abstract][Full Text] [Related]
2. Family-wide characterization of matrix metalloproteinases from Arabidopsis thaliana reveals their distinct proteolytic activity and cleavage site specificity.
Marino G; Huesgen PF; Eckhard U; Overall CM; Schröder WP; Funk C
Biochem J; 2014 Jan; 457(2):335-46. PubMed ID: 24156403
[TBL] [Abstract][Full Text] [Related]
3. Design and characterization of a metalloproteinase inhibitor-tethered resin for the detection of active MMPs in biological samples.
Hesek D; Toth M; Meroueh SO; Brown S; Zhao H; Sakr W; Fridman R; Mobashery S
Chem Biol; 2006 Apr; 13(4):379-86. PubMed ID: 16632250
[TBL] [Abstract][Full Text] [Related]
4. The selectivity of galardin and an azasugar-based hydroxamate compound for human matrix metalloproteases and bacterial metalloproteases.
Sylte I; Dawadi R; Malla N; von Hofsten S; Nguyen TM; Solli AI; Berg E; Adekoya OA; Svineng G; Winberg JO
PLoS One; 2018; 13(8):e0200237. PubMed ID: 30075004
[TBL] [Abstract][Full Text] [Related]
5. Matrix metalloproteinases in plants: a brief overview.
Marino G; Funk C
Physiol Plant; 2012 May; 145(1):196-202. PubMed ID: 22084906
[TBL] [Abstract][Full Text] [Related]
6. Hydroxamate-based peptide inhibitors of matrix metalloprotease 2.
Jani M; Tordai H; Trexler M; Bányai L; Patthy L
Biochimie; 2005; 87(3-4):385-92. PubMed ID: 15781326
[TBL] [Abstract][Full Text] [Related]
7. A new role for old ligands: discerning chelators for zinc metalloproteinases.
Jacobsen FE; Lewis JA; Cohen SM
J Am Chem Soc; 2006 Mar; 128(10):3156-7. PubMed ID: 16522091
[TBL] [Abstract][Full Text] [Related]
8. Protease degradomics: mass spectrometry discovery of protease substrates and the CLIP-CHIP, a dedicated DNA microarray of all human proteases and inhibitors.
Overall CM; Tam EM; Kappelhoff R; Connor A; Ewart T; Morrison CJ; Puente X; López-Otín C; Seth A
Biol Chem; 2004 Jun; 385(6):493-504. PubMed ID: 15255181
[TBL] [Abstract][Full Text] [Related]
9. New beginnings for matrix metalloproteinase inhibitors: identification of high-affinity zinc-binding groups.
Puerta DT; Lewis JA; Cohen SM
J Am Chem Soc; 2004 Jul; 126(27):8388-9. PubMed ID: 15237990
[TBL] [Abstract][Full Text] [Related]
10. Biochemical characterization of the catalytic domain of membrane-type 4 matrix metalloproteinase.
Kolkenbrock H; Essers L; Ulbrich N; Will H
Biol Chem; 1999 Sep; 380(9):1103-8. PubMed ID: 10543448
[TBL] [Abstract][Full Text] [Related]
11. Matrix metalloproteinases operate redundantly in Arabidopsis immunity against necrotrophic and biotrophic fungal pathogens.
Zhao P; Zhang F; Liu D; Imani J; Langen G; Kogel KH
PLoS One; 2017; 12(8):e0183577. PubMed ID: 28832648
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and evaluation of a novel hydroxamate based fluorescent photoprobe for imaging of matrix metalloproteinases.
Faust A; Waschkau B; Waldeck J; Höltke C; Breyholz HJ; Wagner S; Kopka K; Schober O; Heindel W; Schäfers M; Bremer C
Bioconjug Chem; 2009 May; 20(5):904-12. PubMed ID: 19374404
[TBL] [Abstract][Full Text] [Related]
13. Comparison of the pharmacology of hydroxamate- and carboxylate-based matrix metalloproteinase inhibitors (MMPIs) for the treatment of osteoarthritis.
Janusz MJ; Hookfin EB; Brown KK; Hsieh LC; Heitmeyer SA; Taiwo YO; Natchus MG; Pikul S; Almstead NG; De B; Peng SX; Baker TR; Patel V
Inflamm Res; 2006 Feb; 55(2):60-5. PubMed ID: 16612565
[TBL] [Abstract][Full Text] [Related]
14. A protease activity-depleted environment for heterologous proteins migrating towards the leaf cell apoplast.
Goulet C; Khalf M; Sainsbury F; D'Aoust MA; Michaud D
Plant Biotechnol J; 2012 Jan; 10(1):83-94. PubMed ID: 21895943
[TBL] [Abstract][Full Text] [Related]
15. Functional role of matrix metalloproteinases (MMPs) in mammary epithelial cell development.
Lee PP; Hwang JJ; Mead L; Ip MM
J Cell Physiol; 2001 Jul; 188(1):75-88. PubMed ID: 11382924
[TBL] [Abstract][Full Text] [Related]
16. The effect of a hydroxamic acid-containing polymer on active matrix metalloproteinases.
Skarja GA; Brown AL; Ho RK; May MH; Sefton MV
Biomaterials; 2009 Apr; 30(10):1890-7. PubMed ID: 19147221
[TBL] [Abstract][Full Text] [Related]
17. A pan photoaffinity probe for detecting active forms of matrix metalloproteinases.
Nury C; Czarny B; Cassar-Lajeunesse E; Georgiadis D; Bregant S; Dive V
Chembiochem; 2013 Jan; 14(1):107-14. PubMed ID: 23203916
[TBL] [Abstract][Full Text] [Related]
18. Activity-based matrix metallo-protease enrichment using automated, inhibitor affinity extractions.
Freije JR; Klein T; Ooms JA; Franke JP; Bischoff R
J Proteome Res; 2006 May; 5(5):1186-94. PubMed ID: 16674108
[TBL] [Abstract][Full Text] [Related]
19. Future challenges facing the development of specific active-site-directed synthetic inhibitors of MMPs.
Cuniasse P; Devel L; Makaritis A; Beau F; Georgiadis D; Matziari M; Yiotakis A; Dive V
Biochimie; 2005; 87(3-4):393-402. PubMed ID: 15781327
[TBL] [Abstract][Full Text] [Related]
20. Crystal structure of human macrophage elastase (MMP-12) in complex with a hydroxamic acid inhibitor.
Nar H; Werle K; Bauer MM; Dollinger H; Jung B
J Mol Biol; 2001 Sep; 312(4):743-51. PubMed ID: 11575929
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
